Literature DB >> 17385278

The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.

Anna Chiarini1, Ilaria Dal Pra, James F Whitfield, Ubaldo Armato.   

Abstract

Reportedly, beta-amyloid peptides (Abeta40 and Abeta42) induce the neurodegenerative changes of Alzheimer's disease (AD) both directly by interacting with components of the cell surface to trigger apoptogenic signaling and indirectly by activating astrocytes and microglia to produce excess amounts of inflammatory cytokines. A possible cell surface target for Abetas is the p75 neurotrophin receptor (p75(NTR)). By using SK-N-BE neuroblastoma cells without neurotrophin receptors or engineered to express the full-length p75(NTR) or various parts of it, we have proven that p75(NTR) does mediate the Abeta-induced cell killing via its intracellular death domain (DD). This signaling via the DD activates caspase-8, which then activates caspase-3 and apoptogenesis. We also found a strong cytocidal interaction of direct p75(NTR)-mediated and indirect pro-inflammatory cytokine-mediated neuronal damage induced by Abeta. In fact, pro-inflammatory cytokines such as TNF-alpha and IL-1beta from Abeta-activated microglia potentiated the neurotoxic action of Aalpha mediated by p75(NTR) signaling. The pro-inflammatory cytokines probably amplify neuronal damage and killing by causing astrocytes to flood their associated neurons with NO and its lethal oxidizing ONOO- derivative. Indeed, we have found that a combination of three major pro-inflammatory cytokines, IL-1beta+IFN-gamma+TNF-alpha, causes normal adult human astrocytes (NAHA) to express nitric oxide synthase-2 (NOS-2) and make dangerously large amounts of NO via mitogen-activated protein kinases (MAPKs). Soluble Abeta40, the major amyloid precursor protein cleavage product, by itself stimulates astrocytes to express NOS-2 and make NO, possibly by activating p75(NTR) receptors, which they share with neurons, and can considerably amplify NOS-2 expression by the pro-inflammatory cytokine trio. These observations have uncovered a deadly synergistic interaction of Abeta peptides with pro-inflammatory cytokines in the neuron-astrocyte functional units of the AD brain. Finally, we have found that p75(NTR) and its DD also mediate the killing of SK-N-BE human neuroblastoma cells by the prion protein fragment PrP106-126. Thus, neurons expressing p75(NTR) as well as pro-inflammatory cytokine receptors are likely the preferential targets of Abetas and prions and the neurodegenerative diseases they cause.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17385278

Source DB:  PubMed          Journal:  Ital J Anat Embryol        ISSN: 1122-6714


  18 in total

Review 1.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.

Authors:  Edward Tobinick
Journal:  Medscape J Med       Date:  2008-06-10

3.  Role of microglia in ethanol's apoptotic action on hypothalamic neuronal cells in primary cultures.

Authors:  Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

4.  Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease.

Authors:  Mateus Rocha de Paula; Martín Gómez Ravetti; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

Review 5.  Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

6.  Gene expression alterations in Rocky Mountain elk infected with chronic wasting disease.

Authors:  Urmila Basu; Luciane M Almeida; Sandor Dudas; Catherine E Graham; Stefanie Czub; Stephen S Moore; Le Luo Guan
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 7.  Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging.

Authors:  Bindu D Paul; Solomon H Snyder; Vilhelm A Bohr
Journal:  Trends Neurosci       Date:  2020-11-10       Impact factor: 13.837

8.  Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement.

Authors:  Ya-Jen Chiu; Chih-Hsin Lin; Ming-Chung Lee; Hsiu Mei Hsieh-Li; Chiung-Mei Chen; Yih-Ru Wu; Kuo-Hsuan Chang; Guey-Jen Lee-Chen
Journal:  Aging (Albany NY)       Date:  2021-06-09       Impact factor: 5.682

9.  Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats.

Authors:  Lana J Mawhinney; Juan Pablo de Rivero Vaccari; Gordon A Dale; Robert W Keane; Helen M Bramlett
Journal:  BMC Neurosci       Date:  2011-12-01       Impact factor: 3.288

10.  Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.

Authors:  Gretchen Hermes; James W Ajioka; Krystyna A Kelly; Ernest Mui; Fiona Roberts; Kristen Kasza; Thomas Mayr; Michael J Kirisits; Robert Wollmann; David J P Ferguson; Craig W Roberts; Jong-Hee Hwang; Toria Trendler; Richard P Kennan; Yasuhiro Suzuki; Catherine Reardon; William F Hickey; Lieping Chen; Rima McLeod
Journal:  J Neuroinflammation       Date:  2008-10-23       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.